Fellowship · Ann Arbor, MI
Sponsored by University of Michigan
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 468 citations · David Reardon
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Neuro-oncology · 2023 · 466 citations · David Reardon
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro-oncology · 2022 · 470 citations · David Reardon
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The New England journal of medicine · 2023 · 303 citations · Steven Pipe
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
The New England journal of medicine · 2022 · 358 citations · Steven Pipe
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 326 citations ·
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Blood advances · 2021 · 307 citations · Angela Weyand
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.
The New England journal of medicine · 2023 · 177 citations · Angela Weyand